Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-18-017915
Filing Date
2018-07-30
Accepted
2018-07-30 17:20:23
Documents
74
Period of Report
2018-04-30

Document Format Files

Seq Description Document Type Size
1 10-K kalv-10k_20180430.htm 10-K 3159978
2 EX-10.15 kalv-ex1015_183.htm EX-10.15 285177
3 EX-23.1 kalv-ex231_128.htm EX-23.1 2276
4 EX-23.2 kalv-ex232_127.htm EX-23.2 2613
5 EX-31.1 kalv-ex311_131.htm EX-31.1 19750
6 EX-31.2 kalv-ex312_132.htm EX-31.2 19664
7 EX-32.1 kalv-ex321_129.htm EX-32.1 6550
8 EX-32.2 kalv-ex322_130.htm EX-32.2 6705
9 GRAPHIC gi0fz4vcikgu000003.jpg GRAPHIC 9542
10 GRAPHIC gi0fz4vcikgu000001.jpg GRAPHIC 15546
11 GRAPHIC gi0fz4vcikgu000004.jpg GRAPHIC 7185
12 GRAPHIC gi0fz4vcikgu000005.jpg GRAPHIC 19583
13 GRAPHIC gi0fz4vcikgu000002.jpg GRAPHIC 7020
  Complete submission text file 0001564590-18-017915.txt   7705137

Data Files

Seq Description Document Type Size
14 XBRL INSTANCE DOCUMENT kalv-20180430.xml EX-101.INS 1184480
15 XBRL TAXONOMY EXTENSION SCHEMA kalv-20180430.xsd EX-101.SCH 46642
16 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kalv-20180430_cal.xml EX-101.CAL 48900
17 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kalv-20180430_def.xml EX-101.DEF 120403
18 XBRL TAXONOMY EXTENSION LABEL LINKBASE kalv-20180430_lab.xml EX-101.LAB 356033
19 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kalv-20180430_pre.xml EX-101.PRE 270711
Mailing Address ONE KENDALL SQUARE BUILDING 200, STE. 2203 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 200, STE. 2203 CAMBRIDGE MA 02139 (857) 999-0075
KalVista Pharmaceuticals, Inc. (Filer) CIK: 0001348911 (see all company filings)

EIN.: 200915291 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 10-K | Act: 34 | File No.: 001-36830 | Film No.: 18978614
SIC: 2834 Pharmaceutical Preparations